The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase

Journal of Biological Chemistry

Volumn 288, Issue 39, 2013, Pages 27898-27911

  Viswakarma, Navin ^a   Jia, Yuzhi ^a   Bai, Liang ^a   Gao, Qian ^a   Lin, Bingliang ^a   Zhang, Xiaohong ^a   Misra, Parimal ^b   Rana, Ajay ^c   Jain, Sanjay ^d   Gonzalez, Frank J ^e   Zhu, Yi Jun ^a   Thimmapaya, Bayar ^a   Reddy, Janardan K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INSTITUTE OF LIFE SCIENCES   (India)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR ENERGY; ENERGY HOMEOSTASIS; ENERGY METABOLISM; HEPATOCYTE PROLIFERATIONS; MEDIATOR COMPLEX; METABOLIC PATHWAYS; OVER-EXPRESSION; PATHOPHYSIOLOGY;

CELL PROLIFERATION; METABOLISM;

PHOSPHORYLATION;

ADENOVIRUS VECTOR; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MED1 PROTEIN; MEDIATOR COMPLEX; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; SERINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEK293; COMPLEX FORMATION; CONTROLLED STUDY; DNA SYNTHESIS; FATTY ACID OXIDATION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TANDEM MASS SPECTROMETRY;

AMP-ACTIVATED KINASE (AMPK); FATTY ACID OXIDATION; LIVER; LIVER METABOLISM; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR);

ADENYLATE KINASE; ANIMALS; CELL PROLIFERATION; FATTY ACIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEK293 CELLS; HELA CELLS; HEPATOCYTES; HOMEOSTASIS; HUMANS; LIVER; MEDIATOR COMPLEX; MEDIATOR COMPLEX SUBUNIT 1; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXYGEN; PHOSPHORYLATION; PPAR ALPHA;

EID: 84884804685     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.486696     Document Type: Article

References (72)

1. Kornberg, R. (2007) The molecular basis of eukaryotic transcription (Nobel lecture). Angew. Chem. Int. Ed. Engl. 46, 6956-6965
2. Chen, W., and Roeder, R. G. (2011) Mediator-dependent nuclear receptor function. Semin. Cell Dev. Biol. 22, 749-758
3. Kim, Y. J., Björklund, S., Li, Y., Sayre, M. H., and Kornberg, R. D. (1994) A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell 77, 599-608
4. Zhu, Y., Qi, C., Jain, S., Rao, M. S., and Reddy, J. K. (1997) Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J. Biol. Chem. 272, 25500-25506
5. Yuan, C. X., Ito, M., Fondell, J. D., Fu, Z. Y., and Roeder, R. G. (1998) The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl. Acad. Sci. U.S.A. 95, 7939-7944
6. Rachez, C., Lemon, B. D., Suldan, Z., Bromleigh, V., Gamble, M., Näär, A. M., Erdjument-Bromage, H., Tempst, P., and Freedman, L. P. (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828
7. Ryu, S., Zhou, S., Ladurner, A. G., and Tjian, R. (1999) The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature 397, 446-450
8. Frade, R., Balbo, M., and Barel, M. (2000) RB18A, whose gene is localized on chromosome 17q12-q21.1, regulates in vivo p53 transactivating activity. Cancer Res. 60, 6585-6589
9. Ito, M., Yuan, C. X., Okano, H. J., Darnell, R. B., and Roeder, R. G. (2000) Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Mol. Cell 5, 683-693
10. Zhu, Y., Qi, C., Jia, Y., Nye, J. S., Rao, M. S., and Reddy, J. K. (2000) Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality. J. Biol. Chem. 275, 14779-14782
11. Crawford, S. E., Qi, C., Misra, P., Stellmach, V., Rao, M. S., Engel, J. D., Zhu, Y., and Reddy, J. K. (2002) Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors. J. Biol. Chem. 277, 3585-3592
12. Landles, C., Chalk, S., Steel, J. H., Rosewell, I., Spencer-Dene, B., Lalani el-N., and Parker, M. G. (2003) The thyroid hormone receptor-associated protein TRAP220 is required at distinct embryonic stages in placental, cardiac, and hepatic development. Mol. Endocrinol. 17, 2418-2435
13. Jia, Y., Qi, C., Kashireddi, P., Surapureddi, S., Zhu, Y. J., Rao, M. S., Le Roith, D., Chambon, P., Gonzalez, F. J., and Reddy, J. K. (2004) Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPARα)-binding protein, is required for PPARβ-regulated gene expression in liver. J. Biol. Chem. 279, 24427-24434
14. Jia, Y., Guo, G. L., Surapureddi, S., Sarkar, J., Qi, C., Guo, D., Xia, J., Kashireddi, P., Yu, S., Cho, Y. W., Rao, M. S., Kemper, B., Ge, K., Gonzalez, F. J., and Reddy, J. K. (2005) Transcription coactivator peroxisome proliferator-activated receptor-binding protein/Mediator 1 deficiency abrogates acetaminophen hepatotoxicity. Proc. Natl. Acad. Sci. U.S.A. 102, 12531-12536
15. Matsumoto, K., Yu, S., Jia, Y., Ahmed, M. R., Viswakarma, N., Sarkar, J., Kashireddy, P. V., Rao, M. S., Karpus, W., Gonzalez, F. J., and Reddy, J. K. (2007) Critical role for transcription coactivator peroxisome proliferatoractivated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARα ligand-induced liver tumor development. J. Biol. Chem. 282, 17053-17060
16. Matsumoto, K., Huang, J., Viswakarma, N., Bai, L., Jia, Y., Zhu, Y. T., Yang, G., Borensztajn, J., Rao, M. S., Zhu, Y. J., and Reddy, J. K. (2010) Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse. Carcinogenesis 31, 318-325
17. Boden, G., Chen, X., Capulong, E., and Mozzoli, M. (2001) Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50, 810-816
18. Huang, J., Borensztajn, J., and Reddy, J.K. (2011) Hepatic lipid metabolism, in Molecular Pathology of Liver Diseases, Springer Science+Business Media, pp. 133-146, NY, New York
19. Chen, W., Zhang, X., Birsoy, K., and Roeder, R. G. (2010) A muscle-specific knockout implicates nuclear receptor coactivator MED1 in the regulation of glucose and energy metabolism. Proc. Natl. Acad. Sci. U.S.A. 107, 10196-10201
20. Krebs, P., Fan, W., Chen, Y. H., Tobita, K., Downes, M. R., Wood, M. R., Sun, L., Li, X., Xia, Y., Ding, N., Spaeth, J. M., Moresco, E. M., Boyer, T. G., Lo, C. W., Yen, J., Evans, R. M., and Beutler, B. (2011) Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet. Proc. Natl. Acad. Sci. U.S.A. 108, 19678-19682
21. Viswakarma, N., Jia, Y., Bai, L., Vluggens, A., Borensztajn, J., Xu, J., and Reddy, J. K. (2010) Coactivators in PPAR-regulated gene expression. PPARα Res. 10.1155/2010/250126
22. Bai, L., Jia, Y., Viswakarma, N., Huang, J., Vluggens, A., Wolins, N. E., Jafari, N., Rao, M. S., Borensztajn, J., Yang, G., and Reddy, J. K. (2011) Transcription coactivator Mediator subunit MED1 is required for the development of fatty liver in the mouse. Hepatology 53, 1164-1174
23. Jia, Y., Viswakarma, N., Fu, T., Yu, S., Rao, M. S., Borensztajn, J., and Reddy, J. K. (2009) Conditional ablation of Mediator subunit MED1 (MED1/ PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis. Gene Expr. 14, 291-306
24. Walsh, C. (2006) Posttranslational Modification of Proteins: Expanding Nature's Inventory, Roberts and Co. Publishers, Englewood, CO
25. Misra, P., Owuor, E. D., Li, W., Yu, S., Qi, C., Meyer, K., Zhu, Y. J., Rao, M. S., Kong, A. N., and Reddy, J. K. (2002) Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP). Stimulation of transcriptional regulation by mitogen-activated protein kinase. J. Biol. Chem. 277, 48745-48754
26. Belakavadi, M., Pandey, P. K., Vijayvargia, R., and Fondell, J. D. (2008) MED1 phosphorylation promotes its association with Mediator: implications for nuclear receptor signaling. Mol. Cell. Biol. 28, 3932-3942
27. Zhu, Y., Qi, C., Jain, S., Le Beau, M. M., Espinosa, R., 3rd, Atkins, G. B., Lazar, M. A., Yeldandi, A. V., Rao, M. S., and Reddy, J. K. (1999) Amplification and overexpression of peroxisome proliferator-activated receptorbinding protein (PBP/PPARBP) gene in breast cancer. Proc. Natl. Acad. Sci. U.S.A. 96, 10848-10853
28. Chen, Z., Zhang, C., Wu, D., Chen, H., Rorick, A., Zhang, X., and Wang, Q. (2011) Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. The EMBO J. 30, 2405-2419
29. Jin F., Irshad, S., Yu, W., Belakavadi, M., Chekmareva, M., Ittmann, M. M., Abate-Shen, C., and Fondell, J. D. (2013) ERK and AKT signaling drive Med1 overexpression in prostate cancer in association with elevated proliferation and tumorogenicity. Mol. Cancer Res. 11, 736-747
30. Hardie, D. G., Scott, J. W., Pan, D. A., and Hudson, E. R. (2003) Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546, 113-120
31. Carling, D., Thornton, C., Woods, A., and Sanders, M. J. (2012) AMPactivated protein kinase: new regulation, new roles? Biochem. J. 445, 11-27
32. Hardie, D. G., and Alessi, D. R. (2013) LKB1 and AMPK and the cancermetabolism link: ten years after. BMC Biol. 11, 36
33. Hardie, D. G., Ross, F. A., and Hawley, S. A. (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262
34. Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., and Shaw, R. J. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226
35. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., and Moller, D. E. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174
36. Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S. H., Bardeesy, N., Depinho, R. A., Montminy, M., and Cantley, L. C. (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646
37. Shaw, R. J., and Cantley, L. C. (2012) Cell biology. Ancient sensor for ancient drug. Science 336, 813-814
38. Jäger, S., Handschin, C., St-Pierre, J., and Spiegelman, B. M. (2007) AMPactivated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1. Proc. Natl. Acad. Sci. U.S.A. 104, 12017-12022
39. Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y., Gao, B., Wierzbicki, M., Verbeuren, T. J., Shaw, R. J., Cohen, R. A., and Zang, M. (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in dietinduced insulin-resistant mice. Cell Metab. 13, 376-388
40. Solaz-Fuster, M. C., Gimeno-Alcañiz, J. V., Casado, M., and Sanz, P. (2006) TRIP6 transcriptional co-activator is a novel substrate of AMP-activated protein kinase. Cell. Signal. 18, 1702-1712
41. Greer, E. L., Oskoui, P. R., Banko, M. R., Maniar, J. M., Gygi, M. P., Gygi, S. P., and Brunet, A. (2007) The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 282, 30107-30119
42. Hayashi, T., Hirshman, M. F., Kurth, E. J., Winder, W. W., and Goodyear, L. J. (1998) Evidence for 5 AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47, 1369-1373
43. Lee, J. W., Park, S., Takahashi, Y., and Wang, H. G. (2010) The association of AMPK with ULK1 regulates autophagy. PloS One 5, e15394
44. Yu, S., Cao, W. Q., Kashireddy, P., Meyer, K., Jia, Y., Hughes, D. E., Tan, Y., Feng, J., Yeldandi, A. V., Rao, M. S., Costa, R. H., Gonzalez, F. J., and Reddy, J. K. (2001)Humanperoxisome proliferator-activated receptor (PPAR) supports the induction of peroxisome proliferation in PPARβ-deficient mouse liver. J. Biol. Chem. 276, 42485-42491
45. Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., and Gonzalez, F. J. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15, 3012-3022
46. Huang, J., Iqbal, J., Saha, P. K., Liu, J., Chan, L., Hussain, M. M., Moore, D. D., and Wang, L. (2007) Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 46, 147-157
47. Rana, A., Gallo, K., Godowski, P., Hirai, S., Ohno, S., Zon, L., Kyriakis, J. M., and Avruch, J. (1996) The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J. Biol. Chem. 271, 19025-19028
48. Wolf, J., Schliebs, W., and Erdmann, R. (2010) Peroxisomes as dynamic organelles: peroxisomal matrix protein import. FEBS J. 277, 3268-3278
49. Reddy, J. K., and Hashimoto, T. (2001) Peroxisomal β-oxidation and peroxisome proliferator-activated receptor : an adaptive metabolic system. Annu. Rev. Nutr. 21, 193-230
50. Pyper, S. R., Viswakarma, N., Yu, S., and Reddy, J. K. (2010) PPAR: energy combustion, hypolipidemia, inflammation, and cancer. Nucl. Recept. Signal. 8, e002
51. Murakami, H., Murakami, R., Kambe, F., Cao, X., Takahashi, R., Asai, T., Hirai, T., Numaguchi, Y., Okumura, K., Seo, H., and Murohara, T. (2006) Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC. Biochem. Biophys. Res. Commun. 341, 973-978
52. Liangpunsakul, S., Wou, S. E., Wineinger, K. D., Zeng, Y., Cyganek, I., Jayaram, H. N., and Crabb, D. W. (2009) Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase. Arch. Biochem. Biophys. 485, 10-15
53. Meng, R., Pei, Z., Zhang, A., Zhou, Y., Cai, X., Chen, B., Liu, G., Mai, W., Wei, J., and Dong, Y. (2011) AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway. Arch. Biochem. Biophys. 511, 1-7
54. Chen, W. L., Chen, Y. L., Chiang, Y. M., Wang, S. G., and Lee, H. M. (2012) Fenofibrate lowers lipid accumulation in myotubes by modulating the PPAR/AMPK/FoxO1/ATGL pathway. Biochem. Pharmacol. 84, 522-531
55. Bucher, N. L. (1963) Regeneration of mammalian liver. Int. Rev. Cytol. 15, 245-300
56. Michalopoulos, G. K., and DeFrances, M. C. (1997) Liver regeneration. Science 276, 60-66
57. Taub, R. (2004) Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 5, 836-847
58. White, P., Brestelli, J. E., Kaestner, K. H., and Greenbaum, L. E. (2005) Identification of transcriptional networks during liver regeneration. J. Biol. Chem. 280, 3715-3722
59. Riehle, K. J., Dan, Y. Y., Campbell, J. S., and Fausto, N. (2011) New concepts in liver regeneration. J. Gastroenterol. Hepatol. 26, Suppl. 1, 203-212
60. Locker, J., Tian, J., Carver, R., Concas, D., Cossu, C., Ledda-Columbano, G. M., and Columbano, A. (2003) A common set of immediate-early response genes in liver regeneration and hyperplasia. Hepatology 38, 314-325
61. Apte, U., Thompson, M. D., Cui, S., Liu, B., Cieply, B., and Monga, S. P. (2008) Wnt/β-catenin signaling mediates oval cell response in rodents. Hepatology 47, 288-295
62. Sanders, J. A., Schorl, C., Patel, A., Sedivy, J. M., and Gruppuso, P. A. (2012) Postnatal liver growth and regeneration are independent of c-myc in a mouse model of conditional hepatic c-myc deletion. BMC Physiol. 12, 1
63. Reddy, J. K., Rao, M. S., Azarnoff, D. L., and Sell, S. (1979) Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643), in rat and mouse liver. Cancer Res. 39, 152-161
64. Krupczak-Hollis, K., Wang, X., Kalinichenko, V. V., Gusarova, G. A., Wang, I. C., Dennewitz, M. B., Yoder, H. M., Kiyokawa, H., Kaestner, K. H., and Costa, R. H. (2004) The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev. Biol. 276, 74-88
65. Zhang, X., Krutchinsky, A., Fukuda, A., Chen, W., Yamamura, S., Chait, B. T., and Roeder, R. G. (2005) MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription. Mol. Cell 19, 89-100
66. Cui, J., Germer, K., Wu, T., Wang, J., Luo, J., Wang, S. C., Wang, Q., and Zhang, X. (2012) Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells. Cancer Res. 72, 5625-5634
67. Lamy, P. J., Fina, F., Bascoul-Mollevi, C., Laberenne, A. C., Martin, P. M., Ouafik, L., and Jacot, W. (2011) Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers. Breast Cancer Res. 13, R15
68. Hasegawa, N., Sumitomo, A., Fujita, A., Aritome, N., Mizuta, S., Matsui, K., Ishino, R., Inoue, K., Urahama, N., Nose, J., Mukohara, T., Kamoshida, S., Roeder, R. G., and Ito, M. (2012) Mediator subunits MED1 and MED24 cooperatively contribute to pubertal mammary gland development and growth of breast carcinoma cells. Mol. Cell. Biol. 32, 1483-1495
69. Kim, H. J., Roh, M. S., Son, C. H., Kim, A. J., Jee, H. J., Song, N., Kim, M., Seo, S. Y., Yoo, Y. H., and Yun, J. (2012) Loss of Med1/TRAP220 promotes the invasion and metastasis of human non-small-cell lung cancer cells by modulating the expression of metastasis-related genes. Cancer Lett. 321, 195-202
70. Lee, S. K., Lee, J. O., Kim, J. H., Kim, N., You, G. Y., Moon, J. W., Sha, J., Kim, S. J., Lee, Y. W., Kang, H. J., Park, S. H., and Kim, H. S. (2012) Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPARαion in 3T3-L1 preadipocytes. Cell. Signal. 24, 2329-2336
71. Lee W. H., and Kim, S. G. (2010) AMPK-dependent metabolic regulation by PPARα agonists. PPARα Res., dx.doi.org/10.1155/2010/549101
72. Inoki, K., Zhu, T., and Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590